Nov 12 |
Innoviva to Participate in the UBS Global Healthcare Conference
|
Nov 8 |
Innoviva Third Quarter 2024 Earnings: EPS: US$0.019 (vs US$1.26 in 3Q 2023)
|
Nov 7 |
Innoviva GAAP EPS of $0.02, revenue of $89.51M beats by $12.59M
|
Nov 6 |
Innoviva: Q3 Earnings Snapshot
|
Nov 6 |
Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
|
Sep 30 |
Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
|
Sep 4 |
Innoviva to Participate in Upcoming Investor Conferences
|
Sep 4 |
Innoviva's Rollercoaster: Critical Care Bets With Respiratory Backing
|
Jul 31 |
Innoviva: Q2 Earnings Snapshot
|
Jul 31 |
Innoviva GAAP EPS of -$0.55, revenue of $99.9M
|